Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Advocates are working to deliver medication directly to patients to combat this alarming decrease in care.
FDA issued draft guidelines on a new blood donation policy; it now seeks public comment before the changes are finalized.
Less than one third of infants born to mothers with the virus were screened for HCV.
People treated with direct-acting antivirals had a lower risk for liver failure and liver cancer as well as much lower mortality.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Greater political will and financial support for national programs are needed to eliminate viral hepatitis.
The three-drug combination cured most people who had experienced previous treatment failure.
ReLink programs treated 19% of people who were brought back into HCV care after being lost to follow-up.
More than 40% of the 2.4 million Americans with hepatitis C don’t know they’re infected.
Amid this crisis, state and local government officials have enacted laws and ordinances that make clean syringes harder to get.
Even though as many as 97% of patients can be cured with medication, many still don’t receive the treatment.
Current guidelines recommend antiviral treatment regardless of alcohol use.
Black people make up only 6% and Latino people make up 5% of participants in cirrhosis trials in the United States.
Two thirds of people who currently use drugs completed treatment, and most of those were cured.
Fewer people have registered for liver transplants and hepatitis C deaths have been drastically reduced.
Plus: Over 10 prevention services related to hepatitis, HIV and sexually transmitted infections covered by the Affordable Care Act.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.